Endothelial-Derived Microparticles Associate with Hospital Major Adverse Cardiovascular Events but not with Long-Term...

Area of Science:

• Cardiovascular Medicine
• Biomarkers
• Vascular Biology

Background:

• Endothelial-derived microparticles (EDMP) are key indicators of vascular health.
• EDMP play roles in coagulation, inflammation, and apoptosis, relevant to acute myocardial infarction (AMI).

Purpose of the Study:

• To determine if on-admission EDMP levels impact in-hospital major adverse cardiovascular events (MACE) in AMI patients.
• To assess if changes in EDMP levels 30 days post-discharge affect long-term MACE.

Main Methods:

• Prospective cohort study of 119 consecutive AMI patients.
• EDMP measured on admission and 30 days post-discharge.
• In-hospital MACE (cardiac mortality, heart failure, shock, reinfarction, arrhythmia) and long-term follow-up (30 days, 90 days, 1 year) were assessed.

Main Results:

• On-admission EDMP counts were significantly higher in patients with in-hospital MACE (27,421.0 vs. 11,617.5 counts/µL, p=0.028).
• A cutoff of >26,810.0 EDMP/µL predicted increased hospital MACE (aOR: 4.45, p=0.008).
• EDMP counts increased significantly by 30-day post-discharge, but neither admission nor discharge EDMP levels, nor their changes, predicted long-term MACE.

Conclusions:

• Elevated on-admission EDMP levels are independently associated with in-hospital MACE in AMI patients.
• EDMP levels on admission and at 30-day post-discharge, and their changes, do not predict long-term MACE outcomes following AMI.